Inhibitory neurons and glioma: a neural brake on tumor growth

Inhibitory neurons and glioma have an unexpectedly antagonistic relationship, according to a new study. Although neuronal activity is increasingly recognized as a driver of brain tumor growth, researchers have now found neural circuits that can push an adult glioma in the opposite direction.

Gliomas do not simply occupy space among neurons. Previous research has shown that tumor cells can integrate into neural networks and receive synaptic input. Excitatory neuronal activity can increase calcium signaling inside glioma cells and promote tumor progression.

That raised a deceptively simple question: if excitatory circuits can accelerate a tumor, can inhibitory circuits slow it down?

Naofumi Uesaka and colleagues investigated this possibility using experimental models of aggressive adult glioma.

A tumor wired into inhibitory circuits

The researchers first mapped neurons providing direct input to glioma cells. Among them were local inhibitory interneurons that communicate using the neurotransmitter GABA.

Electrophysiological experiments showed that these connections were functional. The tumor cells were not merely sitting near GABAergic neurons; they were receiving synaptic input from them.

The team then manipulated those inhibitory circuits.

Increasing inhibitory tone, using genetic and pharmacological approaches, reduced glioma proliferation and prolonged survival in the experimental animals. Disrupting inhibitory synaptic output produced the opposite result: tumors grew faster.

The surrounding neural circuitry therefore contained both forces capable of promoting tumor growth and forces capable of restraining it.

Calcium provided the mechanistic link

The researchers traced the inhibitory effect to calcium signaling inside glioma cells.

Calcium ions act as powerful intracellular messengers. Changes in calcium dynamics can alter gene regulation, metabolism, proliferation and many other cellular processes.

Activating inhibitory circuits suppressed calcium activity in glioma cells.

The researchers then manipulated calcium dynamics directly. Gain- and loss-of-function experiments showed that tumor calcium activity itself influenced proliferation and survival, providing evidence that calcium was not simply correlated with tumor behavior but was part of the causal pathway.

Two major growth-related signaling programs appeared downstream.

Reduced calcium activity was accompanied by suppression of YAP1-related signaling and mTOR activity. Both pathways can support cellular growth and proliferation.

The emerging mechanism was therefore surprisingly coherent: inhibitory neuronal input reduced calcium dynamics within tumor cells, which in turn weakened oncogenic programs that supported tumor progression.

Not every GABA signal behaves this way

The result also illustrates why the interaction between the nervous system and cancer cannot be reduced to a simple rule.

GABA is generally described as the major inhibitory neurotransmitter of the adult brain, but its effect depends on the physiological state of the receiving cell.

In other brain tumors, including diffuse midline glioma, altered chloride handling can make GABAergic input depolarizing rather than inhibitory. In those settings, GABA-related signaling can promote rather than suppress tumor growth.

The new study therefore does not establish GABAergic signaling as a universal treatment target for brain cancer. It identifies a tumor-suppressive role for inhibitory circuitry in the adult glioma models that were examined.

The distinction is important. What matters may not be neuronal activity in general, but the balance of specific circuit inputs reaching the tumor.

A neural ecosystem around cancer

The experiments are preclinical, and they do not demonstrate that increasing inhibitory neuronal activity can treat glioma in patients.

Manipulating GABAergic signaling in the human brain would also be far from trivial. Inhibitory circuits regulate numerous neurological functions, so changing their activity could have consequences well beyond a tumor.

The conceptual result is nevertheless significant for cancer neuroscience.

A glioma is not simply a collection of malignant cells surrounded by passive brain tissue. It participates in a living neural network, and that network can exert opposing influences on its behavior.

Some neuronal signals provide an accelerator.

Others provide a brake.